by Bone Marrow Transplantation
Researchers describe a novel reduced-intensity conditioning protocol that could potentially resolve a common treatment barrier for adults with sickle cell disease (SCD). Children with SCD...
by Blood Advances
The best timeline for SARS-CoV-2 immunization after undergoing cellular therapy is not known, but recent findings indicate that mRNA SARS-CoV-2 vaccination within 4 months does not appear to...
by Blood
An understanding of extended HLA haplotypes can help narrow down the best choice of haploidentical donor for hematopoietic cell transplantation (HCT), according to results from a multivariable...
by Blood
In vitro and in vivo profiling, along with transcriptomic and metabolomic analyses, showcase the potential of non-activated chimeric antigen receptor (CAR) T-cells as an alternative for tumors...
by Alex Kadhim
This study uses social media insights to reveal the substantial physical, emotional, and financial burden experienced by patients and caregivers living with chronic GVHD in the United States....
by Alex Kadhim
This multinational MAGIC consortium study shows that early use of systemic corticosteroids for grade I acute GVHD does not improve survival outcomes and may increase risks such as...